WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today presented new preclinical data on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback